Home » SfNIRS2022 » Clinical Applications » Classification of Impairment from ∆9-tetrahydrocannabinol (THC) using resting-state neuroimaging

Subscribe to the Newsletter

Click here to subscribe to the fNIRS newsletter and mailing list.
To unsubscribe, click here.

Latest Comments

Click here to see the latest comments and discussions about fNIRS2022 presentations

Just interested in latest general conference updates? Visit the bulletin board

Classification of Impairment from ∆9-tetrahydrocannabinol (THC) using resting-state neuroimaging

By in Clinical Applications, SfNIRS2022 on .

You must be logged in to view this content.